Page last updated: 2024-08-21

malondialdehyde and Bladder Diseases

malondialdehyde has been researched along with Bladder Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albayrak, S; Atar, M; Gurdal, M; Gurel, A; Imamoglu, MA; Sahin, S; Tanik, S; Tuzcu, M; Tuzcu, N; Zengin, K1
Dimitriadis, F; Kinoshita, Y; Martin, DT; Ohmasa, F; Oikawa, R; Oiwa, H; Saito, M; Satoh, I; Shimizu, S; Tomita, S; Tsounapi, P1
Kazuyama, E; Kinoshita, Y; Saito, M; Satoh, I; Satoh, K; Shimizu, S; Tamamura, M1
Aksungar, FB; Ekici, S; Midi, A; Sinanoglu, O; Yener, AN1
Gong, DX; Jiang, YJ; Kong, CZ; Liu, HB; Sun, ZX; Yang, CM1
Horan, P; Levin, RM; Liu, SP; Ohnishi, N1

Other Studies

6 other study(ies) available for malondialdehyde and Bladder Diseases

ArticleYear
Assessment of therapeutic effect of human choriogonadotropin in a chemical cystitis model.
    The Kaohsiung journal of medical sciences, 2017, Volume: 33, Issue:5

    Topics: Animals; Chorionic Gonadotropin; Cystitis; Disease Models, Animal; Female; Glutathione; Humans; Interferon-gamma; Malondialdehyde; Rats; Tumor Necrosis Factor-alpha; Urinary Bladder Diseases

2017
Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.
    Neurourology and urodynamics, 2014, Volume: 33, Issue:3

    Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Disease Models, Animal; Hypertension; Imidazoles; Male; Malondialdehyde; Nerve Growth Factor; NF-E2-Related Factor 2; Nifedipine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Regional Blood Flow; Tetrazoles; Urinary Bladder; Urinary Bladder Diseases; Urodynamics

2014
Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger.
    BJU international, 2009, Volume: 104, Issue:5

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Acute Disease; Animals; Antipyrine; Deoxyguanosine; DNA Damage; Edaravone; Free Radical Scavengers; HSP70 Heat-Shock Proteins; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Urinary Bladder Diseases; Urinary Catheterization; Urinary Retention

2009
The protective effects of spirulina in cyclophosphamide induced nephrotoxicity and urotoxicity in rats.
    Urology, 2012, Volume: 80, Issue:6

    Topics: Animals; Antioxidants; Catalase; Cyclophosphamide; Cystitis; Immunohistochemistry; Immunosuppressive Agents; In Situ Nick-End Labeling; Kidney; Kidney Diseases; Lipid Peroxidation; Malondialdehyde; Oxidative Stress; Rats; Spirulina; Superoxide Dismutase; Urinary Bladder; Urinary Bladder Diseases

2012
Ability of alpha-lipoic acid to reverse the diabetic cystopathy in a rat model.
    Acta pharmacologica Sinica, 2008, Volume: 29, Issue:6

    Topics: Animals; Antioxidants; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Male; Malondialdehyde; Nerve Growth Factor; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thioctic Acid; Urinary Bladder; Urinary Bladder Diseases

2008
Effect of repetitive stimulation on the contractile response of rabbit urinary bladder subjected to in vitro hypoxia or in vitro ischemia followed by reoxygenation.
    Pharmacology, 1998, Volume: 57, Issue:3

    Topics: Animals; Carbachol; Cell Hypoxia; Disease Models, Animal; Electric Stimulation; Glucose; In Vitro Techniques; Ischemia; Lipid Peroxidation; Male; Malondialdehyde; Muscle Contraction; Nitrogen; Oxygen; Potassium Chloride; Rabbits; Reflex, Abnormal; Reperfusion; Time Factors; Urinary Bladder; Urinary Bladder Diseases

1998